Brief: Cipher Pharmaceuticals Inc - QTRLY Total Revenue Increased 20% To $5.8 Million
07/11/2019 12:16
Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS THIRD QUARTER 2019
FINANCIAL
RESULTS
* CIPHER PHARMACEUTICALS INC - QTRLY TOTAL REVENUE INCREASED
20%
TO $5.8 MILLION
* CIPHER PHARMACEUTICALS INC - QTRLY NET LOSS OF $0.08 PER
BASIC
AND DILUTED SHARE
* CIPHER PHARMACEUTICALS INC - SUBSEQUENT TO QUARTER END, ON
OCT
10, CO RECEIVED A NOTICE OF COMPLIANCE FROM HEALTH CANADA
APPROVING SALE OF TRULANCE
Source text for Eikon: ID:nCNWG2cK0a
Further company coverage: CPH.TO
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million